I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Wohlfeiler, Michael B
43
results:
Search for persons
X
Format
Online (43)
Mediatypes
Articles (Online) (30)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
Improving Adherence to the Target Window for Cabotegravir +..:
Wohlfeiler, Michael B.
;
Brunet, Laurence
;
Cochran, Quateka
...
Journal of the International Association of Providers of AIDS Care (JIAPAC). 23 (2024) - p. , 2024
Link:
https://doi.org/10.1177/..
?
2
Cabotegravir + Rilpivirine Long-Acting Injections for HIV T..:
Sension, Michael G.
;
Brunet, Laurence
;
Hsu, Ricky K.
...
Infectious Diseases and Therapy. 12 (2023) 12 - p. 2807-2817 , 2023
Link:
https://doi.org/10.1007/..
?
3
1028. Real-World Use of Long-Acting Cabotegravir + Rilpivir..:
Hsu, Ricky K
;
Sension, Michael
;
Fusco, Jennifer S
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
4
1608. Real-World Effectiveness of Long-Acting Cabotegravir ..:
Sension, Michael
;
Hsu, Ricky K
;
Fusco, Jennifer S
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
5
Perspectives of healthcare providers on implementation of l..:
Czarnogorski, Maggie
;
Garris, Cindy P.
;
Dalessandro, Marybeth
...
Journal of the International AIDS Society. 25 (2022) 9 - p. , 2022
Link:
https://doi.org/10.1002/..
?
6
Perspectives of people living with HIV‐1 on implementation ..:
Garris, Cindy P.
;
Czarnogorski, Maggie
;
Dalessandro, Marybeth
...
Journal of the International AIDS Society. 25 (2022) 9 - p. , 2022
Link:
https://doi.org/10.1002/..
?
7
441. Association between Incident HIV-Associated Wasting/Lo..:
Wohlfeiler, Michael B
;
Weber, Rachel P
;
Brunet, Laurence
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
8
1582. Real-World Use of Long-Acting Cabotegravir + Rilpivir..:
Sension, Michael G
;
Hsu, Ricky K
;
Fusco, Jennifer S
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
9
HIV retention in care: results and lessons learned from the..:
Wohlfeiler, Michael B.
;
Weber, Rachel Palmieri
;
Brunet, Laurence
...
BMC Primary Care. 23 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
10
886. The Impact of the COVID-19 Pandemic on Clinical Follow..:
Pierone, Gerald
;
Fusco, Jennifer S
;
Brunet, Laurence
...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S534-S535 , 2021
Link:
https://doi.org/10.1093/..
?
11
Weight gain before and after switch from TDF to TAF in a U...:
Mallon, Patrick WG
;
Brunet, Laurence
;
Hsu, Ricky K
...
Journal of the International AIDS Society. 24 (2021) 4 - p. , 2021
Link:
https://doi.org/10.1002/..
?
12
Lipid Changes After Switch From TDF to TAF in the OPERA Coh..:
Mallon, Patrick W G
;
Brunet, Laurence
;
Fusco, Jennifer S
...
Open Forum Infectious Diseases. 9 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1093/..
?
13
Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alaf..:
Brunet, Laurence
;
Mallon, Patrick
;
Fusco, Jennifer S.
...
Clinical Drug Investigation. 41 (2021) 11 - p. 955-965 , 2021
Link:
https://doi.org/10.1007/..
?
14
Virologic Outcomes Among People Living With Human Immunodef..:
Mills, Anthony M
;
Schulman, Kathy L
;
Fusco, Jennifer S
...
Open Forum Infectious Diseases. 8 (2021) 8 - p. , 2021
Link:
https://doi.org/10.1093/..
?
15
Virologic Outcomes Among ART-Naïve Individuals Initiating D..:
Mills, Anthony M.
;
Brunet, Laurence
;
Fusco, Jennifer S.
...
Infectious Diseases and Therapy. 9 (2019) 1 - p. 41-52 , 2019
Link:
https://doi.org/10.1007/..
1-15